HomeAUROPHARMA • NSE
add
Aurobindo Pharma Ltd
Previous close
₹1,199.55
Day range
₹1,152.45 - ₹1,191.65
Year range
₹958.50 - ₹1,592.00
Market cap
672.68B INR
Avg Volume
1.10M
P/E ratio
18.90
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 77.96B | 7.99% |
Operating expense | 34.02B | 13.51% |
Net income | 8.17B | 7.95% |
Net profit margin | 10.48 | -0.10% |
Earnings per share | 14.00 | 9.12% |
EBITDA | 15.77B | 16.15% |
Effective tax rate | 32.34% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 68.68B | -3.93% |
Total assets | 480.94B | 9.50% |
Total liabilities | 172.09B | 9.41% |
Total equity | 308.85B | — |
Shares outstanding | 583.84M | — |
Price to book | 2.27 | — |
Return on assets | — | — |
Return on capital | 7.81% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 8.17B | 7.95% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer. Wikipedia
Founded
1986
Headquarters
Website
Employees
26,015
